-
therapies for such cancers, and test them in cellular and animal models. If you thrive in a collaborative environment and have a keen interest in both imaging and treatment of cancer, this role is perfect
-
progression of pancreatic diseases. This project will entail a multi-disciplinary approach involving techniques of molecular biology, cell culture, and bioinformatics as well as animal modeling studies
-
. Desirable Qualifications: Desirable Qualifications: Laboratory skills:in vitro and in vivo studies, flow cytometry, andtechniques in molecular biology Experience with mouse models. Competency in SolidWorks
-
: Desirable Qualifications: Laboratory skills: in vitro and in vivo studies, nanoparticle drug delivery, and RNA therapeutics Experience with mouse models. Competency in SolidWorks, Graphpad, and Adobe
-
on human medicine by studying the impact of novel therapy, screening, or treatment models. Several projects are available and focus on topics such as a pilot project studying lung cancer screening in
-
experiments Design guide RNAs and use CRISPR for gene editing Design AAV vectors for gene therapy on mouse models Capture fluorescent images and quantify data Purify proteins and perform western analyses
-
clinical data, cell culture systems, and mouse models to understand the role of the Hippo pathway and the downstream transcriptional activators TAZ and YAP in sarcomas. Education Requirement: PhD or MD/PhD
-
), and B cell) to pulmonary viral infections and after vaccinations. Applicants should have a strong background in immunology, flow cytometry, as well as experience in rodent models. The selected candidate
-
Department:Pathology Salary Salary:$53,760.00 to Commensurate Position Details Full/Part Time Status:Full Time Percent Time:100% Position Description: By using wild type and genetically modified animal models and
-
function. The candidate will participate in an integrated set of projects aimed at developing a model of the normal human lung against which individuals can be compared to identify and evaluate early